MIR6862-2

Across TCGA pan-cancer cohorts, MIR6862-2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR6862-2 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR6862-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6862-2 expression acts as an unfavorable survival marker.

CESC, OV, and LAML are the cancer types where MIR6862-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.068	0.875	<.001	108	view →
OV	DFS	Tertile	All	0.262	0.541	.019	54	view →
LAML	DFS	Tertile	All	0.138	0.579	<.001	54	view →
BRCA	DFS	Tertile	All	0.133	0.903	<.001	36	view →
KIRC	OS	Tertile	II,III,IV	0.153	0.806	.003	36	view →
THCA	OS	Tertile	All	0.186	0.942	<.001	27	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR6862-2–CESC (OS)

Open the CESC breakdown →